Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
237.04
-0.49 (-0.21%)
At close: Jul 16, 2026, 4:00 PM EDT
237.53
+0.49 (0.21%)
Pre-market: Jul 17, 2026, 8:08 AM EDT
Axsome Therapeutics Stock Forecast
Stock Price Forecast
According to 20 analysts polled by S&P Global, Axsome Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $280.39. The average 1-year stock price forecast is 18.29% higher than the current stock price, while the lowest is $242 (+2.09%) and the highest is $380 (+60.31%).
Price Target: $280.39 (+18.29%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Axsome Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 17 | 17 | 17 | 17 | 17 | 16 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 21 | 21 | 21 | 21 | 21 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains $200 → $380 | Buy | Maintains | $200 → $380 | +60.31% | Jul 16, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $290 | Buy | Reiterates | $290 | +22.34% | Jul 15, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $258 | Buy | Reiterates | $258 | +8.84% | Jul 14, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Reiterates $310 | Buy | Reiterates | $310 | +30.78% | Jul 13, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 10, 2026 |
Financial Forecast
Revenue This Year
978.95M
from 638.50M
Increased by 53.32%
Revenue Next Year
1.59B
from 978.95M
Increased by 62.91%
EPS This Year
-1.70
from -3.47
EPS Next Year
5.87
from -1.70
EPS and Forward PE are based on non-GAAP adjusted numbers.